Evidence map›Paper›PMID 41713943›Full record

Observational studyDiabetes, obesity & metabolism2026

A retrospective observational study evaluating the safety and effectiveness of commercially available automated insulin delivery systems in people with type 1 diabetes and gastroparesis.

Rachael J L Tan, Anusha Ahuja, Aakanksha Shrestha, Geraldine Gallen, Ben Stotesbury, Yee Cheah, Omar G Mustafa, Martin B Whyte, Jonathan Croos, Adam Shooshtarian and 2 more

Abstract readObservational Study
PubMed Full text at PMC Publisher
In one paragraph

Observational study in Diabetes, obesity & metabolism, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Rachael J L TanDiabetes Research Department, Faculty of Life Sciences and Medicine, King's College London, London, UK.ORCID 0000-0003-4013-6810
Anusha AhujaDiabetes Research Department, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Aakanksha ShresthaDiabetes Research Department, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Geraldine GallenDepartment of Diabetes, King's College Hospital NHS Foundation Trust, London, UK.
Ben StotesburyDepartment of Diabetes, King's College Hospital NHS Foundation Trust, London, UK.
Yee CheahDepartment of Diabetes, King's College Hospital NHS Foundation Trust, London, UK.
Omar G MustafaDepartment of Diabetes, King's College Hospital NHS Foundation Trust, London, UK.
Martin B WhyteDepartment of Diabetes, King's College Hospital NHS Foundation Trust, London, UK.
Jonathan CroosDiabetes Research Department, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Adam ShooshtarianDiabetes Research Department, Faculty of Life Sciences and Medicine, King's College London, London, UK.
Bu' Hussain HayeeDepartment of Gastroenterology King's College Hospital NHS Foundation Trust, London, UK.
Marietta StadlerDiabetes Research Department, Faculty of Life Sciences and Medicine, King's College London, London, UK.ORCID 0000-0001-6869-9960

Funding

NIHR Clinical Lectureship CL-2023-17-001NIHR Clinician Scientist Fellowship CS-2017-17-023
6 · The paper itself

Abstract

aimsA retrospective observational cohort study evaluating real-world outcomes in adults with type 1 diabetes and gastroparesis using automated hybrid closed loop insulin delivery systems (HCL). MATERIALS AND

methodsAll adults with type 1 diabetes and gastroparesis attending King's College Hospital diabetes service and using continuous glucose monitoring (CGM) from 5 October 2023 to 16 January 2025 were included. Glycaemic data (HbA

resultsFrom 1827 clinic attendees, 36 adults with gastroparesis were identified, with 17 initiating HCL. HCL and non-HCL groups had comparable baseline characteristics and metrics (HCL: Mean(SD) HbA

conclusionsWithin a specialist multidisciplinary team setting, HCL systems significantly reduce HbA

Indexed as

Diabetes Mellitus, Type 1GastroparesisHypoglycemic AgentsInsulinInsulin Infusion SystemsAdultBlood GlucoseContinuous Glucose MonitoringFemaleGlycated HemoglobinHumansHypoglycemiaMaleMiddle AgedRetrospective StudiesTreatment OutcomeBlood GlucoseGlycated HemoglobinHypoglycemic AgentsInsulinautomated insulin deliveryCGMgastroparesishybrid closed looptype 1 diabetes mellitus

Identifiers

PMID41713943
PMCPMC13071212

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.